Haploidentical Stem Cell Transplantation in Neuroblastoma

NCT00790413 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Neuroblastoma

Interventions

DRUG: iodine I 131 metaiodobenzylguanidine
DRUG: Fludarabine
DRUG: Thiotepa
PROCEDURE: T-cell depletion
PROCEDURE: Haploidentical stem cell transplantation
PROCEDURE: Donor Lymphocyte Infusion
DRUG: Rituximab
PROCEDURE: Co-transplantation of mesenchymal stem cells

Sponsor

Lund University Hospital